Obesity and Hypertension among Nigerians with Impaired Fasting Glucose
DOI:
https://doi.org/10.3923/pjn.2020.266.270Keywords:
Hypertension, impaired fasting glucose, obesity, overweight, pre-diabetesAbstract
Background and Objective: Obesity and hypertension are two important factors associated with the development of prediabetes and overt diabetes mellitus. The prevalence of obesity and hypertension among Nigerians with impaired fasting glucose (IFG), a prediabetic state, is not still fully established. This study therefore intends to determine the prevalence of obesity and hypertension among Nigerians with IFG. Materials and Methods: This was a retrospective study from the available in Special Investigation Clinic of Chemical Pathology Department of the Ekiti State University Teaching Hospital, Ado-Ekiti. Age, sex, systolic and diastolic blood pressure, height and weight were extracted from the record of individuals who presented with two previous IFG (5.6-6.9 mmol L–1) as indication for oral glucose tolerance test (OGTT) over a period of 60 months. Results: A total of 608 subjects comprises of 208 males (34.21%) and 400 females (65.79%) who presented for OGTT on the basis of two previous IFG were recruited. One hundred and seventy six (28.95%) of the patients were found to be obese. Fifty-six (9.21%) had a combination of obesity and systolic BP ≥140 mmHg while 40 (6.58%) had a combination of obesity and diastolic BP ≥90 mmHg. Conclusion: Substantial number of patients with impaired fasting glucose (IFG) has hypertension and obesity.
References
Zimmet, P.Z., 2017. Diabetes and its drivers: the largest epidemic in human history? Clin. Diabetes Endocrinol., Vol. 3, No. 1.
Ozono, R., S. Fujiwara, R. Maeda and Y. Kihara, 2018. Impaired glucose metabolism is associated with visit-to-visit blood pressure variability in participants without cardiovascular disease. Int. J. Hypertensi.
Qian, Y., Y. Lin, T. Zhang, J. Bai and F. Chen et al., 2010. The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population. BMC Public Health, Vol. 10, No. 139.
Ahmad, M.S., S. Iqtadar, S.U. Mumtaz, Z. Niaz, I. Waheed and S. Abaidullah, 2017. Frequency of impaired glucose tolerance in obese patients. Ann. King Edward Med. Univ., 23: 546-549.
Zeng, P., X. Zhu, Y. Zhang, S. Wu, J. Dong, T. Zhang and S. Wang, 2013. Metabolic syndrome and the early detection of impaired glucose tolerance among professionals living in Beijing, China: a cross sectional study. Diabetology Metab. Syndrome, Vol. 5, No. 65.
Liu, L., K. Miura, A. Fujiyoshi, A. Kadota and N. Miyagawa et al., 2014. Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan. Am. J. Cardiol., 113: 84-89.
Liu, A.Y., M.P. Silvestre and S.D. Poppitt, 2015. Prevention of type 2 diabetes through lifestyle modification: is there a role for higher-protein diets? Adv. Nutr., Vol. 6, No. 6 6: 665-673.
Fonseca, V.A., 2008. Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Clin. Cornerstone, 9: 51-61.
Karve, A.M. and R. Hayward, 2010. Prevalence, diagnosis and treatment of impaired fasting glucose and impaired glucose tolerance. J. Am. Coll. Cardiol., 55: E556-E556.
Neumann, A., M. Norberg, O. Schoffer, F. Norström, I. Johansson, S.J. Klug and L. Lindholm, 2013. Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program. BMC Public Health, Vol. 13.
Faeh, D., J. William, P. Yerly, F. Paccaud and P. Bovet, 2007. Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity. Cardiovasc. Diabetology.
Tamayo, T., S. Schipf, C. Meisinger, M. Schunk and W. Maier et al., 2014. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors. PLoS ONE, Vol. 9, No. 11.
Rahim, M.A., A.K.A. Khan, S.M.K Ali, Q. Nahar, A. Shaheen and A. Hussain, 2008. Glucose tolerance in a rural population of Bangladesh. Int. J. Diabetes Dev. Ctries., 28: 45-50.
Yip, W.C.Y., I.R. Sequeira, L.D. Plank and S.D. Poppitt, 2017. Prevalence of pre-diabetes across ethnicities: A review of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) for classification of dysglycaemia. Nutrients, Vol. 9, No. 11.
Li, C., E.S. Ford, G. Zhao and A.H. Mokdad, 2009. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents. Diabetes Care, 32: 342-347.
Williams, D.E., B.L. Cadwell, Y.J. Cheng, C.C. Cowie and E.W. Gregg et al., 2005. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents. Pediatr., 116: 1122-1126.
Tziomalos, K., M. Spanou, M. Baltatzi, E. Efthymiou and K. Psianou et al., 2013. Impaired fasting glucose in hypertensive patients: Prevalence and cross-sectional analysis of associations with cardiovascular disease. Diabetes Technol. Ther., 15: 475-480.
Ogbu, I.S.I. and C.I. Neboh, 2009. The prevalence of prediabetes among hypertensive patients in Enugu, Southeast Nigeria. Niger. Med. J., 50: 14-17.
Papadakis, J.A., K. Papanikolaou, I. Papakitsou, and G. Vrentzos, 2019. Incidence of impaired fasting glucose in patients with essential hypertension in Greece. J. Hypertens, Vol. 37, No. 269.
Lemamsha, H., G. Randhawa and C. Papadopoulos, 2019. Prevalence of overweight and obesity among Libyan men and women. Biomed. Res. Int., Vol. 2019.
Kim, S.H. and G. Reaven, 2010. Obesity and insulin resistance: An ongoing saga. Diabetes, 59: 2105-2106.
Ye, J., 2013. Mechanisms of insulin resistance in obesity. Front. Med., 7: 14-24.
Varghese, R.T., C.D. Man, A. Sharma, I. Viegas and Cristina Barosa et al., 2016. Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans. J. Clin. Endocrinol. Metab., 101: 4816-4824.
Lee, C.J., N.K. Lim, H.C. Kim, S.H. Ihm, H.Y. Lee, H.Y. Park and S.Park, 2015. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: A community cohort study. Am. J. Hypertens., 28: 493-500.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
